{
    "code": 0,
    "data": [
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company has informed the Exchange about Investor Presentation on the Unaudited Financial Results for the quarter and nine months ended December 31 2025.",
            "news_id": "e1e80404-767f-440b-aafc-1298db054f09",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31389bc5-2400-4652-b0b3-705933d141e5.pdf",
            "news_date": "2026-02-12 22:49:40",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company has informed the Exchange about Investor Presentation on the Unaudited Financial Results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31389bc5-2400-4652-b0b3-705933d141e5.pdf",
            "news_date": "2026-02-12 22:49:40"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Q3 FY2026 Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48703480-20e6-4e7f-97ab-a8e86865e6e4.pdf",
            "news_date": "2026-02-12 22:42:34"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting For Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Outcome of the Board Meeting for Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f670aac6-9251-4975-bbd1-5cbbfe7ec82d.pdf",
            "news_date": "2026-02-12 21:31:33"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "news_id": "2968685c-f362-4959-a094-4c2c20864b07",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecb9ada5-afa5-49b5-9374-fc7da2f5d5f0.pdf",
            "news_date": "2026-02-12 21:25:52",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecb9ada5-afa5-49b5-9374-fc7da2f5d5f0.pdf",
            "news_date": "2026-02-12 21:25:52"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation about participating in the Analyst/Institutional Investors Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3db8dbd-5a1a-48e7-bfab-3cc8cf2d1e07.pdf",
            "news_date": "2026-02-10 17:12:16"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Settlement And License Agreement",
            "news_body": "Settlement and License Agreement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37752b47-7ffa-4f7e-85ab-5ce269cf057e.pdf",
            "news_date": "2026-02-10 07:44:26"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Made in India- The story of Desh Bandhu Gupta Lupin and Indian Pharma Book Launched in Mumbai",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9db2355-a33e-41e8-a3d3-a235ff108d70.pdf",
            "news_date": "2026-02-09 11:01:04"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Topiramate Extended-Release Capsules in the United States.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=073347d8-af42-48ec-9b1c-02ae7208b592.pdf",
            "news_date": "2026-02-04 20:43:36"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Dasatinib Tablets in the United States.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dca6345c-b434-42c4-9c78-17a8bc7945c1.pdf",
            "news_date": "2026-02-02 11:13:59"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99059640-8707-44f7-9fd2-e5f5a81d7176.pdf",
            "news_date": "2026-02-02 10:11:08"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Earnings Call for Unaudited Financial Results of Q3 FY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f152d1d8-dd92-47af-9ac0-25dfee58ed4a.pdf",
            "news_date": "2026-01-28 17:26:08"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6588b7ee-f6a3-4b05-8542-9b24580ba186.pdf",
            "news_date": "2026-01-28 16:27:46"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation of allotment of 169140 equity shares under ESOP.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d6a2081-09d8-44c3-be1b-7a511f5c8542.pdf",
            "news_date": "2026-01-27 16:26:23"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ff3e2e3-8d28-41eb-adb8-96320d2e9871.pdf",
            "news_date": "2026-01-23 12:26:36"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfeb88c1-c34b-4279-aa98-9f49e3ba4f06.pdf",
            "news_date": "2026-01-21 07:52:21"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ESG Rating By ESG Risk Assessments And Insights Limited.",
            "news_body": "ESG Rating by ESG Risk Assessments and Insights Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24cbdc28-811a-4c09-9e80-0dc5dd3a75e8.pdf",
            "news_date": "2026-01-19 16:23:37"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication regarding the Notice of Postal Ballot and remote E-Voting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dfb1263-942e-4898-88f9-fd7344895b04.pdf",
            "news_date": "2026-01-15 13:13:22"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of Postal Ballot dated January 06 2026 along with Explanatory Statement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f900cee-a0fd-4dc8-97f3-8f08adb659bb.pdf",
            "news_date": "2026-01-14 16:56:55"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Appointment of Mr. Anand Kripalu as an Additional Director (Non-Executive Independent) effective February 01 2026 and as an Independent Director for a term of five consecutive years with effect from February 01 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5544abde-76f5-4aa9-b58e-41a82472d680.pdf",
            "news_date": "2026-01-06 21:10:10"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg. 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b88c9d52-fcb3-4e0c-82ae-563857be2e2f.pdf",
            "news_date": "2026-01-05 16:17:20"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Update of acquisition of VISUfarma B.V. the Netherlands.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb5bb42a-89b5-4d84-840b-9c39ad572624.pdf",
            "news_date": "2025-12-30 16:29:17"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98cb93fb-d2fc-47c2-81d2-5ffb61c4445c.pdf",
            "news_date": "2025-12-29 18:26:25"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8da0a540-22a5-453a-a77f-517cb9be9b4d.pdf",
            "news_date": "2025-12-26 15:33:53"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Signs Exclusive Licensing Agreement with Neopharmed for Gastroenterology Brand Plasil in the Philippines and Brazil.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7e834f4-289c-424d-be79-5ea8843646c0.pdf",
            "news_date": "2025-12-18 15:50:23"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives Positive CHMP Opinion for Biosimilar Ranibizumab.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=982ed828-f753-4e4b-bd8e-0abb3852e350.pdf",
            "news_date": "2025-12-17 11:53:26"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Receipt of Establishment Inspection Report (EIR) by the Company from the U.S. FDA for its injectables facility in Nagpur India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab0a0f41-45a0-4b0b-8f35-6bf68d524fd7.pdf",
            "news_date": "2025-12-16 20:51:51"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Secures SBTi Validation for Emission Reduction Targets.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afc2a226-3e09-46da-9503-0255cb24d46f.pdf",
            "news_date": "2025-12-16 10:01:29"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to Scale Global Peptide Supply Chain.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5850bafa-1419-44b5-88ec-0ae0904a4f55.pdf",
            "news_date": "2025-12-12 11:47:40"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Newspaper Publication For The Information Regarding Special Window For Re-Lodgement For Transfer Request Of Physical Shares.",
            "news_body": "Newspaper Publication for the information regarding Special Window for re-lodgement for transfer request of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40a5010e-9e36-4060-a382-c91d3bacc561.pdf",
            "news_date": "2025-12-11 17:46:12"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation regarding allotment of 36626 shares under ESOP.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e0d999a-4ed0-4f98-9701-b77805e96672.pdf",
            "news_date": "2025-12-10 16:13:47"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ESG Rating By NSE Sustainability Ratings & Analytics Limited.",
            "news_body": "ESG Rating by NSE Sustainability Ratings & Analytics Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c000ccf2-b5fb-4669-821a-507b0bddc486.pdf",
            "news_date": "2025-12-09 18:01:23"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives Tentative Approval from U.S. FDA for Siponimod Tablets.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe481b71-47c1-4bab-b3e6-01fb9c8bd838.pdf",
            "news_date": "2025-12-05 09:32:07"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79e12861-7454-46f5-a1e4-75cb71fac053.pdf",
            "news_date": "2025-12-04 13:22:15"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg (Pegfilgrastim-unne).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b75d24b-e118-4031-ac37-ad39d069c72e.pdf",
            "news_date": "2025-12-01 07:44:45"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Foundation Earns CRISILs Highest VO 1A Rating for Excellence in Social Responsibility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a581e10b-abf0-4b34-9ddc-f6ff837ec5b1.pdf",
            "news_date": "2025-11-28 11:42:14"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "U.S. FDA Has Conducted An Inspection At Companys Manufacturing Facility Located At Goa India.",
            "news_body": "U.S. FDA has conducted an inspection at Companys manufacturing facility located at Goa India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79d810fb-84ee-4a60-a429-aa09b1816047.pdf",
            "news_date": "2025-11-21 22:47:29"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin announces Closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aeb07c8f-917f-42fb-bb2e-42ea99677855.pdf",
            "news_date": "2025-11-15 16:53:16"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT Exclusivity in the U.S. the first product from its proprietary Long-Acting Injectable platform PrecisionSphere.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12cb6a2b-cc00-4b0c-bc60-d810181a38c5.pdf",
            "news_date": "2025-11-14 07:22:20"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Establishes a New Global Standard in Sustainable Pharma with an S&P Global ESG Score of 91.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d631fc62-1772-45eb-88b9-0e83aba9d980.pdf",
            "news_date": "2025-11-13 12:40:28"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f50a7537-2ae1-4cb0-8e88-5a8bf40242ec.pdf",
            "news_date": "2025-11-12 22:24:11"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY2026 Earnings Conference Call.",
            "news_id": "46ff58c9-9291-4b4b-8854-2c6b95630717",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58fae1c3-739f-4074-952c-e8fae31f5f2c.pdf",
            "news_date": "2025-11-12 15:58:18",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY2026 Earnings Conference Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58fae1c3-739f-4074-952c-e8fae31f5f2c.pdf",
            "news_date": "2025-11-12 15:58:18"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Manufacturing Solutions Unveils Dedicated Oncology Block at Vizag India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=006bce23-47f9-4def-bb31-7011d002908b.pdf",
            "news_date": "2025-11-12 12:57:34"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation about participating in the Analyst/Investors Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce7ceee-3a2c-4899-a696-3c60a47f3a4c.pdf",
            "news_date": "2025-11-10 16:13:12"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After Successful Inspection and Assessment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c81a462b-7125-4806-99ef-0391acaf1164.pdf",
            "news_date": "2025-11-08 12:05:00"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Publication in respect of Unaudited Financial Results of the Company for quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f78c7679-d151-45c9-9d1b-59ce56ba4f7a.pdf",
            "news_date": "2025-11-08 11:57:28"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Link of Audio Recording of the Earnings Call-Q2 FY26.",
            "news_id": "9f21349b-0370-4005-b0fb-e6ab298e0832",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1f4e504-b27f-44db-bcca-ddbfc5c8c3cc.pdf",
            "news_date": "2025-11-07 18:06:29",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Link of Audio Recording of the Earnings Call-Q2 FY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1f4e504-b27f-44db-bcca-ddbfc5c8c3cc.pdf",
            "news_date": "2025-11-07 18:06:29"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company has informed the Exchange about the Investor Presentation on the Unaudited Financial Results for the Quarter and Half Year ended September 30 2025.",
            "news_id": "0aa414d6-b735-405b-9c9d-a1a631c44424",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bcf95d2-421b-4a61-bfdc-4788a5144f81.pdf",
            "news_date": "2025-11-06 19:14:16",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company has informed the Exchange about the Investor Presentation on the Unaudited Financial Results for the Quarter and Half Year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bcf95d2-421b-4a61-bfdc-4788a5144f81.pdf",
            "news_date": "2025-11-06 19:14:16"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Q2 FY2026 Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5c77991-946a-477c-9bd4-a635b69ab847.pdf",
            "news_date": "2025-11-06 18:51:17"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting For Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Outcome of the Board Meeting for Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a515d1d-c53a-41b8-be4b-551443254772.pdf",
            "news_date": "2025-11-06 18:40:18"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025.",
            "news_id": "3ad02819-62c0-4626-9d68-5cb104e0b85a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c325e5e2-fc10-4bc7-aa62-d453622ffb60.pdf",
            "news_date": "2025-11-06 18:30:17",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c325e5e2-fc10-4bc7-aa62-d453622ffb60.pdf",
            "news_date": "2025-11-06 18:30:17"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives EIR from U.S. FDA for its Pithampur Unit-3 Facility",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cf51c7f-b18b-405b-bbad-ed34b387517e.pdf",
            "news_date": "2025-11-05 17:52:20"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement for the intimation regarding Special Window for re-lodgement for transfer request of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ae2f5f0-f6bd-4634-810d-23900f9b3839.pdf",
            "news_date": "2025-10-31 18:10:43"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Digital Health Launches VITALYFE.\r\n.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d602754d-2467-428f-b206-cddfee21494b.pdf",
            "news_date": "2025-10-30 13:52:00"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Inauguration of Lupins New Corporate Offices in Bridgewater New Jersey.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e50b1a85-6681-453b-b62a-e58c1172cc5f.pdf",
            "news_date": "2025-10-28 15:54:36"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation regarding allotment of 4312 shares under ESOPs.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b78a86a3-c26c-4ba5-909c-caadc58d1bb7.pdf",
            "news_date": "2025-10-28 15:41:04"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Earnings Call for Unaudited Financial Results of Q2 FY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0caba3a5-e70e-49d8-b8bc-7d82acf3d255.pdf",
            "news_date": "2025-10-27 18:01:53"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Authorized Generic Version of Ravicti in the United States.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e6d9c90-4002-4e49-8ead-dd0c98639d35.pdf",
            "news_date": "2025-10-24 09:37:25"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Taking On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4976d74-6ceb-4dde-9960-46afd71ffd29.pdf",
            "news_date": "2025-10-22 16:25:12"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2285da89-d635-4dc5-af0e-cade68872402.pdf",
            "news_date": "2025-10-13 14:48:02"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "U.S. FDA Has Conducted A Pre-Approval Inspection At The Companys Manufacturing Facility Located In Somerset New Jersey U.S.A.",
            "news_body": "U.S. FDA has conducted a Pre-Approval Inspection at the Companys manufacturing facility located in Somerset New Jersey U.S.A.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5e48bb6-9732-43cc-8d29-49cd8c249cb9.pdf",
            "news_date": "2025-10-11 12:10:02"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation regarding grant of 14649 stock options under ESOP.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa9c84a3-2847-4491-8445-16eeeed5170f.pdf",
            "news_date": "2025-10-10 20:10:20"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de667760-de14-4fd7-a556-80aa596ba0f5.pdf",
            "news_date": "2025-10-09 15:04:57"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs Florida U.S.A.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8892580-4028-4711-b033-b2781d5df0d2.pdf",
            "news_date": "2025-10-08 18:30:22"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19672b63-1d67-482c-a0e8-fe50ee149158.pdf",
            "news_date": "2025-10-07 18:04:14"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "U.S. FDA Has Determined The Inspection Of Companys Pithampur Unit-2 Manufacturing Facility As Official Action Indicated.",
            "news_body": "U.S. FDA has determined the inspection of Companys Pithampur Unit-2 manufacturing facility as Official Action Indicated.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83ec86df-7ddf-4b5a-a27e-7385799ce253.pdf",
            "news_date": "2025-10-04 12:33:45"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Liraglutide Injection in the United States.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3eb94cc-505d-429e-adc8-ca4979939760.pdf",
            "news_date": "2025-10-03 18:12:28"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Rivaroxaban for Oral Suspension in the United States.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e08ed18-c7b1-4174-9362-9b4ae879026c.pdf",
            "news_date": "2025-10-01 15:01:16"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives Approval from U.S. FDA for Rivaroxaban for Oral Suspension.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e013e7d7-073f-4cd4-a051-147ade464258.pdf",
            "news_date": "2025-09-30 16:55:46"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Retirement of Senior Management Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80e43c2d-b552-4b42-a414-5d5afd0930f0.pdf",
            "news_date": "2025-09-30 16:04:19"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Nanomi B.V. the Netherlands a wholly owned subsidiary of the Company in Netherlands has entered into a definitive agreement to acquire the entire share capital of VISUfarma B.V. headquartered in Amsterdam the Netherlands.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30ddb298-5bf0-4e26-a464-51bf86a32d96.pdf",
            "news_date": "2025-09-29 06:49:33"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89d392cd-7e76-46f0-9d02-b21c9decca8b.pdf",
            "news_date": "2025-09-26 16:32:54"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Details of voting results of the business transacted by way of Postal Ballot along with report of the Scrutinizer.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7bcb497-0709-446c-92bb-90488d8b0fb7.pdf",
            "news_date": "2025-09-25 20:58:06"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Details of voting results of the business transacted by way of Postal Ballot along with report of the Scrutinizer.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de3d567c-144f-4617-a5a5-6c9c25546346.pdf",
            "news_date": "2025-09-25 20:54:20"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives Tentative Approval from U.S. FDA for Bictegravir Emtricitabine and Tenofovir Alafenamide Tablets.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51c48da2-5b2a-4f2e-8c73-29ebf1a7bc76.pdf",
            "news_date": "2025-09-24 16:44:44"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation regarding allotment of 3351 shares under ESOP.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbe71329-fe4e-4e76-bc4d-c2d2ceb9cb7e.pdf",
            "news_date": "2025-09-23 11:13:39"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "U.S. FDA Has Conducted A Product-Specific Pre-Approval Inspection At The CompanyS Pune Biotech Facility.",
            "news_body": "U.S. FDA has conducted a product-specific Pre-Approval Inspection at the Companys Pune Biotech facility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4798e492-e2ed-43cc-a2af-75b2dcce5cd0.pdf",
            "news_date": "2025-09-20 13:49:12"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives Approval from U.S. FDA for Lenalidomide Capsules.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b39faec-0695-4ec5-90cf-2881c04ff0fe.pdf",
            "news_date": "2025-09-17 13:08:46"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "U.S. FDA Has Conducted An Inspection Of CompanyS Injectable Facility At Nagpur.",
            "news_body": "U.S. FDA has conducted an inspection of Companys Injectable facility at Nagpur.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d61c74e6-9ed9-461b-8cc1-bc814461a2ed.pdf",
            "news_date": "2025-09-16 21:24:55"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ESG Rating By ESG Risk Assessments And Insights Limited.",
            "news_body": "ESG Rating by ESG Risk Assessments and Insights Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac01a078-c168-4b93-ae2c-b91923ac9a36.pdf",
            "news_date": "2025-09-13 12:32:02"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation about participating in the Analyst/Investors Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2dab416-3f8d-43a1-97f8-3f1f5cd48bd1.pdf",
            "news_date": "2025-09-11 12:08:34"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "U.S. FDA Has Conducted A Product-Specific Pre-Approval Inspection At The CompanyS Chhatrapati Sambhajinagar (Aurangabad) Manufacturing Facility",
            "news_body": "U.S. FDA has conducted a product-specific Pre-Approval Inspection at the Companys Chhatrapati Sambhajinagar (Aurangabad) manufacturing facility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa203320-bbfa-48a1-b8f1-9847e3c4aaf1.pdf",
            "news_date": "2025-09-06 09:04:33"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for the information regarding Special Window for re-lodgement for transfer request of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=753abbb2-93a2-40f7-b502-035b1d11af54.pdf",
            "news_date": "2025-09-03 16:05:42"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable with 180-Day CGT Exclusivity the First Product from its Nanomis Long-Acting Injectable Platform.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a3532de-d189-43e0-841a-731f843b0acc.pdf",
            "news_date": "2025-09-03 13:04:10"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ESG Rating By Crisil ESG Ratings & Analytics Ltd.",
            "news_body": "ESG Rating by Crisil ESG Ratings & Analytics Ltd.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ca1d2fe-1a05-42d4-ac5f-3c7f117b7201.pdf",
            "news_date": "2025-08-29 11:08:51"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation about participating in the Analyst/Investors Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70ab3ab4-5034-4b9f-8ab5-136020ad2749.pdf",
            "news_date": "2025-08-27 13:46:06"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copies of Newspaper Publication with respect to dispatch of Postal Ballot Notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0c3f00e-0ddc-4eee-a318-9326e73940c7.pdf",
            "news_date": "2025-08-27 13:32:30"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of Postal Ballot dated August 20 2025 along with explanatory Statement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46d783b-d9ea-4f4f-abad-d73641d7d1ec.pdf",
            "news_date": "2025-08-26 15:35:59"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation regarding allotment of 7189 shares under ESOP.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8487d17a-ff47-4ba1-acec-ce6ccd52676f.pdf",
            "news_date": "2025-08-21 12:52:59"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Re-appointment of Mr. Mark D. McDade Independent Director for Second term of five consecutive years.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7b33b2a-6ad3-4aa7-a958-0ccbb939d067.pdf",
            "news_date": "2025-08-20 18:20:25"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Bosentan Tablets for Oral Suspension in the United States with 180-Day Exclusivity.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b1f03d5-90fa-44e2-bfaf-fde7a044ee8c.pdf",
            "news_date": "2025-08-20 10:13:24"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Announces Licensing Deal for Ranibizumab Biosimilar.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d08b33c-cf63-42fd-9a89-c4dfb311a50c.pdf",
            "news_date": "2025-08-12 10:55:55"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Completion of term of Mr. Jean-Luc Belingard as an Independent Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d374cb2f-e9a4-4223-aa36-a718a83f5fca.pdf",
            "news_date": "2025-08-11 22:08:34"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Details of Voting Results of Forty-Third Annual General Meeting of the Company and Consolidated Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9818bc89-9014-4266-a3a8-4dd36db6b14f.pdf",
            "news_date": "2025-08-11 21:47:07"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of the Forty-Third Annual General Meeting held on August 11 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df15ada7-24c5-4fc8-8a43-e40002d69d39.pdf",
            "news_date": "2025-08-11 21:38:49"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY2026 Earnings Conference Call.",
            "news_id": "6863fb59-3c3a-4770-8b1f-6f66072de17b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75514df9-518b-4d3c-973e-56cea6a63ade.pdf",
            "news_date": "2025-08-11 12:13:21",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY2026 Earnings Conference Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75514df9-518b-4d3c-973e-56cea6a63ade.pdf",
            "news_date": "2025-08-11 12:13:21"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Lupin Launches Glucagon for Injection USP 1mg/Vial in the United States.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05c156de-3716-4dc4-be07-b50c6ab2ce0c.pdf",
            "news_date": "2025-08-11 10:23:41"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation about participating in the Analyst / Institutional Investors Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=648de4f4-cc5d-4038-882e-26422628fe1b.pdf",
            "news_date": "2025-08-08 17:57:28"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Publication in respect of Unaudited Financial Results of the Company for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90ca8387-4b83-40bf-bfa0-3c2f742db981.pdf",
            "news_date": "2025-08-07 16:19:19"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Earnings Call-Q1 FY26",
            "news_id": "e1b4e6fb-80b4-40b4-b371-06c2ea65cbf4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f43ba81a-506a-41dd-9587-6a13a139f313.pdf",
            "news_date": "2025-08-06 19:07:54",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Earnings Call-Q1 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f43ba81a-506a-41dd-9587-6a13a139f313.pdf",
            "news_date": "2025-08-06 19:07:54"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company has informed the Exchange about Investor Presentation on the Unaudited Financial Results for the quarter ended on June 30 2025.",
            "news_id": "7a7bfe8b-7c1f-45c9-ad45-201c95c93b88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d1ec720-157a-4541-9887-ee92480f028c.pdf",
            "news_date": "2025-08-06 09:26:35",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3026,
            "bse_code": 500257,
            "isin": "INE326A01037",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company has informed the Exchange about Investor Presentation on the Unaudited Financial Results for the quarter ended on June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d1ec720-157a-4541-9887-ee92480f028c.pdf",
            "news_date": "2025-08-06 09:26:35"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025.",
            "news_body": "Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025.",
            "news_id": "7c7600a8-b706-49eb-a036-8a64ff614732",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0722fe03-4c2d-46bf-954d-977d3a04e9fa.pdf",
            "news_date": "2025-08-05 20:40:18",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Investors Meet 2025",
            "news_id": "46b692cb-ffff-40df-917a-010def0dce88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=086b5197-121c-40d1-b56d-a0b63cdd2cd0.pdf",
            "news_date": "2025-05-21 16:10:35",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The link of audio recording of the Investors Meet 2025 is available on the website of the Company at https://www.lupin.com/audio/q4-fy25-earnings-call.mp3.",
            "news_id": "7d7c88b0-c87f-4aa8-a2f8-c7c28522ed45",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4783c9b6-9cb6-4bca-896c-a82523df253a.pdf",
            "news_date": "2025-05-15 22:22:33",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation to be made at the Investors Meet 2025.",
            "news_id": "c96cb0e7-3819-44a9-8f5f-4159a23268b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dec76331-be46-44f2-9a37-b7441c4cd47f.pdf",
            "news_date": "2025-05-15 17:28:03",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31 2025 And Recommend Final Dividend Of Rs. 12/- Per Equity Share I.E. 600 % Of The Face Value Of Rs. 2/ Each Fully Paid Up For The Financial Year Ended March 31 2025",
            "news_body": "Approval of the Audited Financial Statements for the quarter and year ended March 31 2025 and recommend the Final Dividend of Rs. 12/- per Equity Share i.e. 600 % of the Face Value of Rs. 2/- each fully paid up for the financial year ended March 31 2025.",
            "news_id": "21a53664-38e5-4b9a-a973-9e4b37d48437",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9b3b31b-39aa-487f-a477-e617fa88b7c6.pdf",
            "news_date": "2025-05-14 22:24:26",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31 2025 And Recommend Final Dividend Of Rs. 12/- Per Equity Share I.E. 600 % Of The Face Value Of Rs. 2/ Each Fully Paid Up For The Financial Year Ended March 31 2025",
            "news_body": "Approval of the Audited Financial Statements for the quarter and year ended March 31 2025 and recommend the Final Dividend of Rs. 12/- per Equity Share i.e. 600 % of the Face Value of Rs. 2/- each fully paid up for the financial year ended March 31 2025.",
            "news_id": "51649ce2-e2ce-4d99-ba79-352857da9a9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70fd76fe-dc4c-4647-8407-8b33b0e68e8f.pdf",
            "news_date": "2025-05-14 22:22:12",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY2025 Earnings Conference Call.",
            "news_id": "93daae0c-309f-411a-b74b-b4231f2e8854",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59e892e8-fd89-4c21-8eb0-8e19f5f40202.pdf",
            "news_date": "2025-02-19 17:32:20",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 FY25",
            "news_id": "97953bca-e325-45a8-8401-7e0e881cc1b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d47b6012-941d-4e6d-8aad-c6f1abdb6ec5.pdf",
            "news_date": "2025-02-12 02:42:36",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2024.",
            "news_body": "Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine-months ended December 31 2024.",
            "news_id": "e6012b23-a1d6-4d5d-81e5-8ad406281e47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fab4ab66-ed38-410c-b95c-9aae6b853879.pdf",
            "news_date": "2025-02-12 00:45:44",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY25 Earnings Conference Call.",
            "news_id": "460f7554-21b0-4508-9be3-0d3f657c7a5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c54399e-97a5-492e-ab81-030fab890433.pdf",
            "news_date": "2024-11-13 18:13:38",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Earnings Call - Q2 FY25.",
            "news_id": "8cb36771-f611-4b0f-888c-4565cbe2cc8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef5d01e3-4499-4a19-9d23-2725132a6253.pdf",
            "news_date": "2024-11-08 20:52:23",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q2 FY25",
            "news_id": "01eff5c9-9f27-4345-b683-7775b2b1827d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9985eed-0d03-4244-93cf-46b0cb42bdf8.pdf",
            "news_date": "2024-11-07 20:13:15",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024.",
            "news_body": "Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024.",
            "news_id": "c4b315c4-a425-4c91-9227-65fccfb11383",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=757946d0-17a3-4108-9a7f-b1413d04158e.pdf",
            "news_date": "2024-11-07 18:34:10",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY2025 Earnings Conference Call.",
            "news_id": "e35b4cb2-407a-47ac-809e-5d4c477a31e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b110148-17ca-4011-8d33-f1dd5f7bb19c.pdf",
            "news_date": "2024-08-13 16:38:29",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Earnings Call - Q1 FY25",
            "news_id": "ca5ca0b7-950b-44d8-a971-6b5953bb7e8a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=525bf35d-0c9a-45de-9f2f-21c6e1c4b7cb.pdf",
            "news_date": "2024-08-07 21:03:05",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation-Q1 FY25",
            "news_id": "a68fd469-81a5-4596-bff3-77075e7f8802",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=371ce5dd-f54b-405b-9c94-8594f163635a.pdf",
            "news_date": "2024-08-06 21:52:39",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024.",
            "news_body": "Unaudited Financial Results for the Quarter ended June 30, 2024.",
            "news_id": "cd25c674-cfef-45b2-b8c1-b86f1e3153dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2a949e8-7136-40b5-9d92-d273f874a6dc.pdf",
            "news_date": "2024-08-06 21:03:41",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Q4 FY2024 Earnings Conference call held on Tuesday, May 7, 2024.",
            "news_id": "6e1440ea-f7b6-44f8-9d5e-adc06c6c1e74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eff54d97-ef44-44db-8971-10fa71452dc7.pdf",
            "news_date": "2024-05-14 15:14:08",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Earnings Call - Q4 FY24.",
            "news_id": "13649660-4ed5-4a45-a4f0-1f1e0c788862",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a7f94df-3820-4b8b-98c4-d9a99932b93e.pdf",
            "news_date": "2024-05-07 21:21:21",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q4 FY24",
            "news_id": "4d97d420-ccad-4058-bcfa-5f90f8d009bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d78dc3b2-fd5d-447e-8ecb-165ef9f6ee40.pdf",
            "news_date": "2024-05-07 12:06:45",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024.",
            "news_body": "Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2024.",
            "news_id": "974fa139-fb96-4f2d-944a-2c2857c14fc1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75dc7261-c3f0-4ab6-9343-f7a440ba6a3d.pdf",
            "news_date": "2024-05-06 20:36:07",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY2024 Earnings Conference Call.",
            "news_id": "6120d724-48bc-4e56-9f66-3b0ef97e5807",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76879903-8b4f-423a-be54-ca61f1e715c3.pdf",
            "news_date": "2024-02-14 14:34:25",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings Call - Q3 FY24.",
            "news_id": "ce113795-6d08-4e4d-8963-35b3a6ee5c4f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46eca99-880d-43b3-89a8-27dda859e719.pdf",
            "news_date": "2024-02-08 18:57:58",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 FY24",
            "news_id": "0edea518-9863-4d2b-b738-954c92faa666",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9fc4f25-032c-48b0-ae6f-df7ed744a404.pdf",
            "news_date": "2024-02-08 12:54:52",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine-Months Ended December 31, 2023.",
            "news_body": "Unaudited Financial Results for the quarter and nine-months ended December 31, 2023.",
            "news_id": "98db2edf-aa1d-4c66-872d-ac6c961bffa1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f27d6bb-e8fa-48b8-abec-4faa584c8c06.pdf",
            "news_date": "2024-02-07 19:39:29",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Q2 FY2024 Earnings Conference Call.",
            "news_id": "d3b0934d-9068-4b09-8cd8-1f296edf89c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa080325-9c18-4b9f-ad92-086f38fa09fc.pdf",
            "news_date": "2023-11-17 14:40:48",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Earnings Call - Q2 FY24.",
            "news_id": "95cf2d41-5dfa-4091-ab57-c58c81f8a24e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=742d434a-6269-408b-8d74-f64fa2dd1b4b.pdf",
            "news_date": "2023-11-09 23:01:05",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 FY24.",
            "news_id": "4087ab3a-49b5-402f-838a-25c2fb9ff881",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bddbf37-caf5-4817-8333-77c6a881bdfd.pdf",
            "news_date": "2023-11-08 23:07:06",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half-Year Ended September 30, 2023.",
            "news_body": "Unaudited Financial Results for the quarter and half-year ended September 30, 2023.",
            "news_id": "b79deb37-9faa-4026-aca7-6948c0e68a98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=178910d7-522f-4da3-afd8-01095d6de622.pdf",
            "news_date": "2023-11-08 22:56:05",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Q1 FY2024 Earnings Conference Call held on Friday, August 4, 2023.",
            "news_id": "0571b374-a939-41ba-a4e1-b7aa2651c811",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a3b2de6-af09-48fd-aae5-b2068618a3e5.pdf",
            "news_date": "2023-08-11 14:51:26",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Earnings Call - Q1 FY24.",
            "news_id": "a9c38aaa-d8c5-47d6-a838-3915f47eaee8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2ad1c7c-a564-4b09-913a-6a1cddc45cad.pdf",
            "news_date": "2023-08-04 23:02:01",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY24",
            "news_id": "7c54aaac-0c1b-47f2-b9d4-7dad0279ea7c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b07c6fd7-4e1f-4690-b4b5-2641893592ef.pdf",
            "news_date": "2023-08-04 16:10:44",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2023.",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2023.",
            "news_id": "b05093e2-552b-4b89-845e-559d84064b49",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6797e0b0-c956-48d8-ae08-73cdf6b97cf4.pdf",
            "news_date": "2023-08-03 22:00:24",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Q4 FY2023 Earnings Conference Call held at 16.00 hrs (IST)on Wednesday, May 10, 2023.",
            "news_id": "94f8f4e1-4d00-47c7-895c-399b7752ba23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=818cde79-3ec6-47ee-8b11-84eac1f0f40c.pdf",
            "news_date": "2023-05-16 18:14:05",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio/Video recording of the Earnings Call - Q4 FY 2023.",
            "news_id": "c431e696-3499-4ce9-abb4-06a7e3ea2a1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc9966a2-ca34-4ab3-8358-bd4675da9ecb.pdf",
            "news_date": "2023-05-10 20:56:38",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4 FY23.",
            "news_id": "03f10f38-2816-4218-916f-babb985f481e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bca13dc6-97a5-434f-8fa8-109bb4f37833.pdf",
            "news_date": "2023-05-10 16:02:25",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Statements For The Quarter And Year Ended March 31, 2023.",
            "news_body": "Audited Financial Statements for the quarter and year ended March 31, 2023.",
            "news_id": "b312c70a-2d5c-4038-baff-62289b5c726f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36aca095-71c1-45cb-bb3c-0357232f8c11.pdf",
            "news_date": "2023-05-09 22:37:25",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY2023 Earnings Conference Call.",
            "news_id": "b1e3df2d-0a9b-4626-b468-74a6fb327b41",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f162f2c5-bb31-41de-b144-9c3515d8963c.pdf",
            "news_date": "2023-02-16 21:38:11",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Link of audio recording of the Earnings Call - Q3 FY 2023.",
            "news_id": "3c54f367-114e-483d-bb9c-1ab281cd879b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e7ed95a-94d4-44f6-8c1f-1bb2b023a265.pdf",
            "news_date": "2023-02-11 11:58:07",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 FY 23.",
            "news_id": "baf0d242-d0b4-48f1-8045-4311d352a6fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f3d9af8-e1c9-44bd-aba5-8e8c4ec37499.pdf",
            "news_date": "2023-02-10 16:07:40",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Of The Company Along With Limited Review Report For The Quarter And Nine-Months Ended December 31, 2022.",
            "news_body": "Unaudited standalone and consolidated financial results of the Company along with Limited Review Report for the quarter and nine-months ended December 31, 2022.",
            "news_id": "c16daf80-a003-4de4-81c3-df42a24e22b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69d0935d-b644-4dac-b82c-59fd0295fc1d.pdf",
            "news_date": "2023-02-09 21:56:44",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "J. P Morgan Healthcare Conference, US.",
            "news_id": "cd86b7a3-eefe-4302-b07d-1c8b91d9b9d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1e68125-bf69-4f4d-8398-65651c3b4c1d.pdf",
            "news_date": "2023-01-11 04:51:16",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2022",
            "news_body": "Disclosure of Related Party Transactions for the half year ended September 30, 2022",
            "news_id": "ed9a83b3-e7f5-44fc-b981-9297dbc75bc3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d248cb32-c7a6-4d4d-9f00-00a0c92b1e78.pdf",
            "news_date": "2022-11-23 14:19:40",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY2023 Earnings Conference Call.",
            "news_id": "eed77b89-61e6-4a19-9fb6-2c2b82f96ce8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2759bc22-cb69-4d3e-a298-e1fc972d0316.pdf",
            "news_date": "2022-11-16 10:51:28",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio/Video recording of the Earnings Call - Q2 FY 2022-23.",
            "news_id": "a06a959c-da83-4f81-aa00-c30f54dd8b9b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4db1b068-1191-4a27-93a1-6e8be106de34.pdf",
            "news_date": "2022-11-10 19:44:06",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 FY23.",
            "news_id": "fd3c6090-4c9c-48b3-a5d4-625d50121eb5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0635e0d2-18db-4616-adcf-9ef678128676.pdf",
            "news_date": "2022-11-10 14:21:51",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Along With Limited Review Reports For The Quarter And Half-Year Ended September 30, 2022.",
            "news_body": "Unaudited standalone and consolidated financial results along with Limited Review Reports for the quarter and half-year ended September 30, 2022.",
            "news_id": "1bcf8907-d44c-4873-ad32-02ad63ea97f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d418728-b07e-4ec5-a949-3dc2a3d54ac0.pdf",
            "news_date": "2022-11-09 20:11:56",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Q1 FY2023 Earnings Conference Call held on Thursday, August 4, 2022.",
            "news_id": "a0ed071c-1d89-4826-8469-8cd69fdf1474",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5139c00b-dfb6-4f56-92b3-1deecfa2301e.pdf",
            "news_date": "2022-08-09 15:13:04",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY23",
            "news_id": "d081e08d-5061-410a-a6a8-61361ae1ab1d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5402ad5d-dc2c-48e6-b973-0f2a8e51ff0d.pdf",
            "news_date": "2022-08-04 16:35:33",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Along With Limited Review Reports For The Quarter Ended June 30, 2022.<BR> <BR>",
            "news_body": "Unaudited standalone and consolidated financial results along with Limited Review Reports for the quarter ended June 30, 2022.",
            "news_id": "bc140510-56ec-4c0f-966a-8b0b5b6ccf2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9d86ea2-928f-4868-9513-d4b04a4b52e9.pdf",
            "news_date": "2022-08-03 22:35:02",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half-YearEnded March 31, 2022.",
            "news_body": "Disclosure of Related Party Transactions for the half-yearended March 31, 2022.",
            "news_id": "8f47e698-5f2c-4002-813e-f49dd90ca8ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dba83567-ea80-4bb7-9739-b786766a8e1d.pdf",
            "news_date": "2022-06-02 22:26:12",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4 FY2022 Investor Meet/Earnings Conference Call.",
            "news_id": "b3802dc5-0f1f-4ee9-8a13-a8748fcfcc6d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ff4832b-693b-498a-a733-a19c47e3322d.pdf",
            "news_date": "2022-05-25 15:01:19",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio/Video recording of the Investor Presentation FY 2021-22.",
            "news_id": "54caa884-e55e-4ed4-bf25-30be29e00ae0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4193a863-3c85-4cb0-b5b7-ac4cb7166334.pdf",
            "news_date": "2022-05-19 22:02:30",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation FY 2021-22.",
            "news_id": "af78645f-2ec2-45b0-94f0-1bc91e9183f3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d31d2d7-b0e1-4c01-ae07-e5aab765dcaa.pdf",
            "news_date": "2022-05-19 15:41:45",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Statements For The Quarter And  Year Ended March 31, 2022.",
            "news_body": "Audited Financial Statements for the quarter and year ended March 31, 2022.",
            "news_id": "f801d08c-30d8-45a8-82c3-4705e4db98e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f5e0784-3ba3-42a1-a685-a9d3bf9c8fa1.pdf",
            "news_date": "2022-05-18 20:33:37",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY2022 Earnings Conference Call on February 4, 2022",
            "news_id": "a380feba-5b10-4e19-9a49-a666933c422f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdb5e7f5-4b60-49ae-84dc-81de8befab81.pdf",
            "news_date": "2022-02-13 18:40:07",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 FY2022.",
            "news_id": "5cb41998-4501-46ad-80ed-4a6b88873ca0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=081e8ce5-9ee3-465b-9f47-67fac3f5cf0b.pdf",
            "news_date": "2022-02-04 15:52:25",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine-Months Ended December 31, 2021.",
            "news_body": "Unaudited standalone and consolidated financial results for the quarter and nine-months ended December 31, 2021.",
            "news_id": "ec0ba133-d1e6-4dc2-8110-e378c91978a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a319243-562c-4b56-8208-81e57eb05b5d.pdf",
            "news_date": "2022-02-03 23:29:03",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "J.P Morgan Healthcare Conference Presentation",
            "news_id": "f1e3af28-b404-4a4b-ae48-4ef898678fcd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21308fb0-82b9-459e-9e6d-8a545c661c8d.pdf",
            "news_date": "2022-01-12 18:40:28",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 FY2022 Earnings Conference Call",
            "news_id": "14fa78cc-b8ca-40d3-9b3f-951d99e9d0fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3773103e-f647-492f-9e89-4a95720ac3ca.pdf",
            "news_date": "2021-11-10 18:30:36",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 FY2022.",
            "news_id": "6cc88bfd-1bc7-46e2-bfb4-06e9dab7956b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27bebab6-054f-40d5-8032-efb125a3011a.pdf",
            "news_date": "2021-10-28 20:28:14",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half-Year Ended September 30, 2021.",
            "news_body": "Unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2021.",
            "news_id": "3c9244ef-e835-4a06-9a0b-690b4fc670e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c36879f8-2f87-48c3-ac67-7a6c6b2dbaa7.pdf",
            "news_date": "2021-10-27 23:04:45",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY2022 Earnings Conference Call.",
            "news_id": "874a0843-22bb-4527-96a3-7a00ba0f1bad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c56a3264-cbb2-440d-adb8-eee75ef49d26.pdf",
            "news_date": "2021-08-26 18:07:32",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1 FY2022 Investor Presentation.",
            "news_id": "66590f6a-d133-4d2d-9a3b-328b70df0295",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2e82fda-8a60-49c4-a9f7-ca3977f8e55b.pdf",
            "news_date": "2021-08-11 19:21:23",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2021.",
            "news_body": "Unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2021.",
            "news_id": "4d6fa689-bc07-4ca2-9ebc-7d9288ddb204",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e68f81af-6bc0-48ec-886c-47236fb81859.pdf",
            "news_date": "2021-08-10 22:30:27",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Lupin Limited Q4 FY2021 Earnings Conference Call Transcript.",
            "news_id": "e9a00bf7-39ac-42ba-bcc1-4eafa07b6a4a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2613d62-ecc8-44b6-a82f-985b90930e62.pdf",
            "news_date": "2021-05-25 13:02:08",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4 FY2021.",
            "news_id": "e6ed0d07-3f24-48b8-8529-9f7c9ce31411",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0d687c5-a216-455a-b8be-37682750e523.pdf",
            "news_date": "2021-05-13 17:32:51",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LUPIN",
            "disp": "Lupin",
            "bse_code": 500257,
            "isin": "INE326A01037",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For March 2021",
            "news_body": "Audited Results for March 2021",
            "news_id": "d06a3420-0ab3-44e3-9111-0d94204063ef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2c8a6f5-7a3a-4a9a-9e6f-22a0d62db062.pdf",
            "news_date": "2021-05-13 00:15:40",
            "seo": "lupin-ltd",
            "ltp": 2209.1,
            "ch": 5,
            "pch": 0.22684996143550656,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 10440,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}